331 related articles for article (PubMed ID: 17156374)
1. Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains.
McLin JP; Thompson LM; Steward O
Eur J Neurosci; 2006 Dec; 24(11):3134-40. PubMed ID: 17156374
[TBL] [Abstract][Full Text] [Related]
2. Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid mouse strains.
McLin JP; Steward O
Eur J Neurosci; 2006 Oct; 24(8):2191-202. PubMed ID: 17074044
[TBL] [Abstract][Full Text] [Related]
3. Genes on distal chromosome 18 determine vulnerability to excitotoxic neurodegeneration following status epilepticus, but not striatal neurodegeneration induced by quinolinic acid.
McLin JP; Thompson LM; Lusis AJ; Davis RC; Steward O
Neurobiol Dis; 2008 Mar; 29(3):391-9. PubMed ID: 17996456
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to excitotoxic and metabolic striatal neurodegeneration in the mouse is genotype dependent.
Schauwecker PE
Brain Res; 2005 Apr; 1040(1-2):112-20. PubMed ID: 15804432
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
Petersén A; Chase K; Puschban Z; DiFiglia M; Brundin P; Aronin N
Exp Neurol; 2002 May; 175(1):297-300. PubMed ID: 12009780
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of sensitivity to hippocampal cell death induced by kainic acid: a quantitative trait loci analysis.
Schauwecker PE; Williams RW; Santos JB
J Comp Neurol; 2004 Sep; 477(1):96-107. PubMed ID: 15281082
[TBL] [Abstract][Full Text] [Related]
7. Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains of mice.
Inman D; Guth L; Steward O
J Comp Neurol; 2002 Sep; 451(3):225-35. PubMed ID: 12210135
[TBL] [Abstract][Full Text] [Related]
8. Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice.
Otani N; Nawashiro H; Fukui S; Ooigawa H; Ohsumi A; Toyooka T; Shima K; Gomi H; Brenner M
J Clin Neurosci; 2006 Nov; 13(9):934-8. PubMed ID: 17085299
[TBL] [Abstract][Full Text] [Related]
9. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity.
Liang ZQ; Wang XX; Wang Y; Chuang DM; DiFiglia M; Chase TN; Qin ZH
Neurobiol Dis; 2005 Nov; 20(2):562-73. PubMed ID: 15922606
[TBL] [Abstract][Full Text] [Related]
11. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation.
Zourlidou A; Gidalevitz T; Kristiansen M; Landles C; Woodman B; Wells DJ; Latchman DS; de Belleroche J; Tabrizi SJ; Morimoto RI; Bates GP
Hum Mol Genet; 2007 May; 16(9):1078-90. PubMed ID: 17360721
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity.
DeMarch Z; Giampà C; Patassini S; Martorana A; Bernardi G; Fusco FR
Neurobiol Dis; 2007 Feb; 25(2):266-73. PubMed ID: 17184995
[TBL] [Abstract][Full Text] [Related]
13. Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background.
Strong MK; Southwell AL; Yonan JM; Hayden MR; Macgregor GR; Thompson LM; Steward O
J Huntingtons Dis; 2012; 1(2):221-41. PubMed ID: 23833693
[TBL] [Abstract][Full Text] [Related]
14. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
Bazzett TJ; Becker JB; Kaatz KW; Albin RL
Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
[TBL] [Abstract][Full Text] [Related]
15. The impact of genetic background on neurodegeneration and behavior in seizured mice.
Mohajeri MH; Madani R; Saini K; Lipp HP; Nitsch RM; Wolfer DP
Genes Brain Behav; 2004 Aug; 3(4):228-39. PubMed ID: 15248868
[TBL] [Abstract][Full Text] [Related]
16. Differences in ionotropic glutamate receptor subunit expression are not responsible for strain-dependent susceptibility to excitotoxin-induced injury.
Schauwecker PE
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):70-81. PubMed ID: 12670704
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in susceptibility to kainic acid-induced neurodegeneration in aged C57BL/6 mice.
Zhang XM; Zhu SW; Duan RS; Mohammed AH; Winblad B; Zhu J
Neurotoxicology; 2008 May; 29(3):406-12. PubMed ID: 18342945
[TBL] [Abstract][Full Text] [Related]
18. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome.
Roberts RC; Ahn A; Swartz KJ; Beal MF; DiFiglia M
Exp Neurol; 1993 Dec; 124(2):274-82. PubMed ID: 8287926
[TBL] [Abstract][Full Text] [Related]
19. IGF2 knockout mice are resistant to kainic acid-induced seizures and neurodegeneration.
Dikkes P; B Jaffe D; Guo WH; Chao C; Hemond P; Yoon K; Zurakowski D; Lopez MF
Brain Res; 2007 Oct; 1175():85-95. PubMed ID: 17870057
[TBL] [Abstract][Full Text] [Related]
20. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
